Table 1.
Clinical characteristics of study patients.
| AD (group 1) baseline before FPP supplementation | AD (group 2) not supplemented | Controls without AD | ||
|---|---|---|---|---|
| Age (years) | 78.1 ± 1.1 | 78.3 ± 1.0 | 77.9 ± 1.2 | NS |
| 8-OHdG (ng/mL) | 14.1 ± 1.7 | 12.5 ± 1.9 | 1.6 ± 0.12 | <0.001 |
| SBP (mmHg) | 132.9 ± 1.9 | 130.7 ± 2.1 | 131.0 ± 2.3 | NS |
| DBP (mmHg) | 78.6 ± 1.1 | 77.7 ± 1.2 | 77.9 ± 1.2 | NS |
| CHOL (mg/dL) | 207.9 ± 39 | 205.8 ± 38 | 195.7 ± 41 | NS |
| TG (mg/dL) | 127.5 ± 47 | 118 ± 57 | 112 ± 49 | NS |
| HDL (mg/dL) | 43.8 ± 12 | 47.9 ± 14 | 47.6 ± 13 | NS |
| LDL (mg/dL) | 136.8 ± 35 | 128.9 ± 40 | 127.7 ± 41 | NS |
| BMI | 24.9 ± 5.5 | 24.8 ± 6.4 | 24.1 ± 6.1 | NS |
| MMSE | 22.1 ± 1.5 | 21.9 ± 1.4 | 28.8 ± 2.1 | P < 0.01 |